Saikosaponin A Inhibits Triple-Negative Breast Cancer Growth and Metastasis Through Downregulation of CXCR4
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Saikosaponin A Inhibits Triple-Negative Breast Cancer Growth and Metastasis Through Downregulation of CXCR4
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-01-28
DOI
10.3389/fonc.2019.01487
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Growth inhibitory efficacy of Cornus�officinalis in a cell culture model for triple‑negative breast cancer
- (2019) Nitin Telang et al. Oncology Letters
- Editorial: Metastasis: From Cell Adhesion and Beyond
- (2019) Vasiliki Gkretsi et al. Frontiers in Oncology
- Eribulin Synergistically Increases Anti-Tumor Activity of an mTOR Inhibitor by Inhibiting pAKT/pS6K/pS6 in Triple Negative Breast Cancer
- (2019) Wei Wen et al. Cells
- Targeting the PI3K/AKT/mTOR pathway in triple-negative breast cancer: a review
- (2018) Ricardo L. B. Costa et al. BREAST CANCER RESEARCH AND TREATMENT
- Knockdown of CXCR4 Inhibits CXCL12-Induced Angiogenesis in HUVECs through Downregulation of the MAPK/ERK and PI3K/AKT and the Wnt/β-Catenin Pathways
- (2018) Zhi-Yu Song et al. CANCER INVESTIGATION
- Balixafortide plus eribulin in HER2-negative metastatic breast cancer: a phase 1, single-arm, dose-escalation trial
- (2018) Sonia Pernas et al. LANCET ONCOLOGY
- CXCL12 chemokine and CXCR4 receptor: association with susceptibility and prognostic markers in triple negative breast cancer
- (2018) Alda Losi Guembarovski et al. MOLECULAR BIOLOGY REPORTS
- Peptide density targets and impedes triple negative breast cancer metastasis
- (2018) Daxing Liu et al. Nature Communications
- A comprehensive review and perspectives on pharmacology and toxicology of saikosaponins
- (2018) Xiaojiaoyang Li et al. PHYTOMEDICINE
- CXCL12/CXCR4 promotes proliferation, migration, and invasion of adamantinomatous craniopharyngiomas via PI3K/AKT signal pathway
- (2018) Xiaohong Yin et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Anticancer efficiency of cycloartane triterpenoid derivatives isolated from Cimicifuga yunnanensis Hsiao on triple-negative breast cancer cells
- (2018) Xiao Li et al. Cancer Management and Research
- Potential anticancer effect of prostratin through SIK3 inhibition
- (2017) Dalal Alotaibi et al. Oncology Letters
- Triple-negative breast cancer has worse overall survival and cause-specific survival than non-triple-negative breast cancer
- (2016) Xiaoxian Li et al. BREAST CANCER RESEARCH AND TREATMENT
- A new oridonin analog suppresses triple-negative breast cancer cells and tumor growth via the induction of death receptor 5
- (2016) Jing Wu et al. CANCER LETTERS
- Cancer-associated fibroblasts promote the progression of endometrial cancer via the SDF-1/CXCR4 axis
- (2016) Fei Teng et al. Journal of Hematology & Oncology
- Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
- (2016) Giampaolo Bianchini et al. Nature Reviews Clinical Oncology
- A fully human CXCR4 antibody demonstrates diagnostic utility and therapeutic efficacy in solid tumor xenografts
- (2016) Babak Behnam Azad et al. Oncotarget
- CXCR4/CXCL12/CXCR7 axis is functional in neuroendocrine tumors and signals on mTOR
- (2016) Luisa Circelli et al. Oncotarget
- The re-emergence of natural products for drug discovery in the genomics era
- (2015) Alan L. Harvey et al. NATURE REVIEWS DRUG DISCOVERY
- Breast cancer in China
- (2014) Lei Fan et al. LANCET ONCOLOGY
- Inhibiting Metastatic Breast Cancer Cell Migration via the Synergy of Targeted, pH-triggered siRNA Delivery and Chemokine Axis Blockade
- (2014) Peng Guo et al. MOLECULAR PHARMACEUTICS
- Cytoplasmic CXCR4 High-Expression Exhibits Distinct Poor Clinicopathological Characteristics and Predicts Poor Prognosis in Triple-Negative Breast Cancer
- (2013) H.-W. Chen et al. CURRENT MOLECULAR MEDICINE
- Osteopontin Enhances the Expression and Activity of MMP-2 via the SDF-1/CXCR4 Axis in Hepatocellular Carcinoma Cell Lines
- (2011) Rihua Zhang et al. PLoS One
- A CXCR4 Antagonist CTCE-9908 Inhibits Primary Tumor Growth and Metastasis of Breast Cancer
- (2008) Eugene H. Huang et al. JOURNAL OF SURGICAL RESEARCH
- High Chemokine Receptor CXCR4 Level in Triple Negative Breast Cancer Specimens Predicts Poor Clinical Outcome
- (2008) Quyen D. Chu et al. JOURNAL OF SURGICAL RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started